Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Citi
Merck
Dow
Colorcon
US Department of Justice
Baxter
Deloitte
Fish and Richardson

Generated: January 22, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Ganitumab

« Back to Dashboard

US Patents for Ganitumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ganitumab ➤ Sign Up Multispecific constructs AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Sign Up
Ganitumab ➤ Sign Up Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Sign Up
Ganitumab ➤ Sign Up P97 fragments with transfer activity biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) ➤ Sign Up
Ganitumab ➤ Sign Up Meditopes and meditope-binding antibodies and uses thereof City of Hope (Duarte, CA) ➤ Sign Up
Ganitumab ➤ Sign Up Fragments of p97 and uses thereof biOasis Technologies, Inc. (Richmond, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Ganitumab

Drugname Country Document Number Estimated Expiration Related US Patent
Ganitumab Canada 2900764 2033-02-08 ➤ Sign Up
Ganitumab European Patent Office 2954056 2033-02-08 ➤ Sign Up
Ganitumab Hong Kong 1218930 2033-02-08 ➤ Sign Up
Ganitumab Japan 2016509014 2033-02-08 ➤ Sign Up
Ganitumab World Intellectual Property Organization (WIPO) 2014124326 2033-02-08 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Chubb
Argus Health
Farmers Insurance
UBS
Express Scripts
Julphar
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.